Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, June 3, 2019
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
[ Mon, Jun 03rd 2019
] - WOPRAI
Fri, May 31, 2019
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
[ Fri, May 31st 2019
] - WOPRAI
Thu, May 30, 2019
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
[ Thu, May 30th 2019
] - WOPRAI
Mohit Bansal Initiated (ADAP) at Strong Buy and Held Target at $8 on, May 30th, 2019
Mohit Bansal of Citigroup, Initiated "Adaptimmune Therapeutics plc" (ADAP) at Strong Buy and Held Target at $8 on, May 30th, 2019.
Mohit has made no other calls on ADAP in the last 4 months.
There is 1 other peer that has a rating on ADAP. Out of the 1 peers that are also analyzing ADAP, all agrees with Mohit's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jonathan Chang of "SVB Leerink" Downgraded from Buy to Hold on, Tuesday, May 7th, 2019
